These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25748709)
21. Detection of Toxocara canis DNA in tissues of experimentally infected mice. Moura MQ; Macedo MRP; Terto WDDS; Avila LFDC; Leivas Leite FP; Scaini CJ; Pinto NB; Capella GA; Strothmann AL; Villela MM; Berne MEA Acta Trop; 2018 Nov; 187():51-56. PubMed ID: 30053384 [TBL] [Abstract][Full Text] [Related]
22. Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice. Leal-Silva T; Vieira-Santos F; Oliveira FMS; Padrão LLS; Kraemer L; da Paixão Matias PH; de Almeida Lopes C; Loiola Ruas AC; de Azevedo IC; Nogueira DS; Rachid MA; Caliari MV; Castro Russo R; Fujiwara RT; Bueno LL PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009639. PubMed ID: 34324507 [TBL] [Abstract][Full Text] [Related]
23. Toxocara in the mouse: a model for parasite-altered host behaviour? Holland CV; Cox DM J Helminthol; 2001 Jun; 75(2):125-35. PubMed ID: 11520435 [TBL] [Abstract][Full Text] [Related]
24. Analysis of serum cytokine levels in children with chronic cough associated with Toxocara canis infection. Nagy D; Bede O; Danka J; Szénási Z; Sipka S Parasite Immunol; 2012 Dec; 34(12):581-8. PubMed ID: 23009389 [TBL] [Abstract][Full Text] [Related]
25. EFFICACY OF NITAZOXANIDE AGAINST Toxocara canis: LARVAL RECOVERY AND HUMORAL IMMUNE RESPONSE IN EXPERIMENTALLY INFECTED MICE. Lescano SA; Santos SV; Assis JM; Chieffi PP Rev Inst Med Trop Sao Paulo; 2015; 57(4):337-41. PubMed ID: 26422159 [TBL] [Abstract][Full Text] [Related]
26. Influence of murine Toxocara canis infection on plasma and bronchoalveolar lavage fluid eosinophil numbers and its correlation with cytokine levels. Pecinali NR; Gomes RN; Amendoeira FC; Bastos AC; Martins MJ; Pegado CS; Bastos OM; Bozza PT; Castro-Faria-Neto HC Vet Parasitol; 2005 Nov; 134(1-2):121-30. PubMed ID: 16168564 [TBL] [Abstract][Full Text] [Related]
28. Effect of immunomodulation on the course of experimental toxocariasis in mice. Mohamed NH; Soffar SA; Sabry NM; Makled KM; Otifa NM J Egypt Soc Parasitol; 1994 Dec; 24(3):671-83. PubMed ID: 7844434 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis. Dent LA; Daly CM; Mayrhofer G; Zimmerman T; Hallett A; Bignold LP; Creaney J; Parsons JC Infect Immun; 1999 Feb; 67(2):989-93. PubMed ID: 9916122 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of follow-up of therapy with fenbendazole incorporated into stabilized liposomes and immunomodulator glucan in mice infected with Toxocara canis larvae. Hrckova G; Velebný S; Obwaller A; Auer H; Kogan G Acta Trop; 2007; 104(2-3):122-32. PubMed ID: 17915186 [TBL] [Abstract][Full Text] [Related]
31. A murine model for cerebral toxocariasis: characterization of host susceptibility and behaviour. Hamilton CM; Stafford P; Pinelli E; Holland CV Parasitology; 2006 Jun; 132(Pt 6):791-801. PubMed ID: 16476184 [TBL] [Abstract][Full Text] [Related]
32. Influence of maternal infection on offspring immune response in murine larval toxocariasis. Reiterová K; Tomasovicová O; Dubinský P Parasite Immunol; 2003 Jul; 25(7):361-8. PubMed ID: 14521578 [TBL] [Abstract][Full Text] [Related]
33. Behavioural changes and muscle strength in Rattus norvegicus experimentally infected with Toxocara cati and T. canis. Santos SV; Moura JV; Lescano SA; Castro JM; Ribeiro MC; Chieffi PP J Helminthol; 2015 Jul; 89(4):465-70. PubMed ID: 24725503 [TBL] [Abstract][Full Text] [Related]
34. Toxocara canis: larval migration dynamics, detection of antibody reactivity to larval excretory-secretory antigens and clinical findings during experimental infection of gerbils (Meriones unguiculatus). Alba-Hurtado F; Muñoz-Guzmán MA; Valdivia-Anda G; Tórtora JL; Ortega-Pierres MG Exp Parasitol; 2009 May; 122(1):1-5. PubMed ID: 19545524 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of eosinophilia in BALB/c-nu/+ and congenitally athymic BALB/c-nu/nu mice infected with Toxocara canis. Kusama Y; Takamoto M; Kasahara T; Takatsu K; Nariuchi H; Sugane K Immunology; 1995 Mar; 84(3):461-8. PubMed ID: 7751031 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the immunosuppressive effect of cyclophosphamide and dexamethasone in mice with visceral toxocariasis. da Costa de Avila LF; da Fonseca JS; Dutra GF; de Lima Telmo P; Silva AM; Berne ME; da Silva PE; Conceição FR; Scaini CJ Parasitol Res; 2012 Jan; 110(1):443-7. PubMed ID: 21748353 [TBL] [Abstract][Full Text] [Related]
37. Toxocara-induced hepatic inflammation: immunohistochemical characterization of lymphocyte subpopulations and Bcl-2 expression. Othman AA; Ashour DS; Mohamed DA Exp Parasitol; 2013 May; 134(1):76-81. PubMed ID: 23462071 [TBL] [Abstract][Full Text] [Related]
38. Modulation of IL-12 and IFNγ by probiotic supplementation promotes protection against Toxocara canis infection in mice. de Avila LF; de Leon PM; de Moura MQ; Berne ME; Scaini CJ; Leivas Leite FP Parasite Immunol; 2016 May; 38(5):326-30. PubMed ID: 26971490 [TBL] [Abstract][Full Text] [Related]
39. The hamster (Mesocricetus auratus) as an experimental model of toxocariasis: histopathological, immunohistochemical, and immunoelectron microscopic findings. da Silva AM; Chieffi PP; da Silva WL; Kanashiro EH; Rubinsky-Elefant G; Cunha-Neto E; Mairena EC; De Brito T Parasitol Res; 2015 Mar; 114(3):809-21. PubMed ID: 25518818 [TBL] [Abstract][Full Text] [Related]
40. Toxocara canis: effect of inoculum size on pulmonary pathology and cytokine expression in BALB/c mice. Pinelli E; Brandes S; Dormans J; Fonville M; Hamilton CM; der Giessen Jv Exp Parasitol; 2007 Jan; 115(1):76-82. PubMed ID: 16908022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]